Skip to content
OpenCapital
Get started

Opko Health OPK Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Current

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Current at other companies

LAD
Lithia MotorsLAD
$421.3M-2.1%
Inter Parfums logo
Inter ParfumsIPAR
$158.09M+26.0%
Clarivate logo
ClarivateCLVT
$242.2M-31.6%
HRO
HarrowHROW
$94.64M+41.8%
SM Energy logo
SM EnergySM
$449M—
Oaktree Specialty Lending logo
Oaktree Specialty LendingOCSL
$51.26M-52.6%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.14B+11.5%
P/S2×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0×0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept opk:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's cash cash equivalents restricted cash and restricted cash equivalents current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's cash cash equivalents restricted cash and restricted cash equivalents current?
Opko Health (OPK) reported cash cash equivalents restricted cash and restricted cash equivalents current of $341.88M in Q1 2026.
How has Opko Health's cash cash equivalents restricted cash and restricted cash equivalents current changed year-over-year?
Opko Health's cash cash equivalents restricted cash and restricted cash equivalents current decreased by 21.6% year-over-year, from $436M to $341.88M.
What is the long-term trend for Opko Health's cash cash equivalents restricted cash and restricted cash equivalents current?
Over 2 years (2023 to 2025), Opko Health's cash cash equivalents restricted cash and restricted cash equivalents current has grown at a 96.2% compound annual growth rate (CAGR), from $95.88M to $369.07M.
What does cash cash equivalents restricted cash and restricted cash equivalents current mean?
This represents the total liquid assets available to the company, including cash on hand, bank deposits, and cash equivalents that can be converted to cash within 90 days. It also includes restricted cash balances that are legally set aside for specific purposes and are not available for general operating use. This metric is a primary indicator of a company's immediate liquidity and its ability to meet short-term obligations.